Tuberculosis, orchestrated by Mycobacterium tuberculosis, emerged as a global peril, fueled by the ascent of drug-resistant strains. This urgency catalyzes the imperative creation of novel drugs. Mycobacterial ribosomal studies unveil unique traits, hinting at translation adaptations—potential game-changers for drug and non-drug therapies. Our focus extends to Mycobacterial phage interactions, unravelling new drug sites and enriching our comprehension of host-pathogen dynamics.

Writing Plag-free content according to the client's requirements.

Currently working as an analyst for training biological questions for large language models and AI annotator.